The European Commission published a report on pharmacovigilance activities related to medicines for human use in the EU covering the years 2012-2014.
Notes on verification
Confirmed by official EUR-Lex record (CELEX 52016DC0498), the Commission's own PDF, EMA's legislation page, and industry press. Minor discrepancy between August 2016 adoption date and April 2017 date cited by secondary source does not undermine the core claim. [tier=silver indep_score=0.925 clusters=2 claim_tier=everyday | framework convergence=single on European Commission's official legislative report COM(2016) 498 final and its accompanying Staff Working Document SWD(2016) 284 final (upstreams: European Commission (COM(2016) 498 final), EUR-Lex official record CELEX 52016DC0498) — publishers independent, evidence may not be | kind=attributed eligibility=high]
Sources
- Farmacoepidemiologia documentazione in Europa (seed:health_and_medicine)
- https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:52016DC0498 (corroboration)
- https://ec.europa.eu/health/sites/health/files/files/pharmacovigilance/pharmacovigilance-report-2012-2014_en.pdf (corroboration)
- https://health.ec.europa.eu/document/download/d6a3e4ac-e924-478f-a6d7-6d71384bdc2c_en (corroboration)
- https://www.pharmexec.com/view/european-commission-publishes-pharmacovigilance-report-1 (corroboration)